Global Vaccine Adjuvants Industry

NEW YORK, Oct. 29, 2019 /PRNewswire/ -- Vaccine Adjuvants market worldwide is projected to grow by US$492.1 Million, driven by a compounded growth of 10.2%. Particulate Adjuvants, one of the segments analyzed and sized in this study, displays the potential to grow at over 10.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$337.2 Million by the year 2025, Particulate Adjuvants will bring in healthy gains adding significant momentum to global growth.

Download the full report: https://www.reportbuyer.com/product/5799883/?utm_source=PRN

- Representing the developed world, the United States will maintain a 11.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$22 Million to the region's size and clout in the next 5 to 6 years. Over US$22.9 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Particulate Adjuvants will reach a market size of US$30.1 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 9.7% over the next couple of years and add approximately US$83.7 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include, among others, Agenus, Inc.; Avanti Polar Lipids, Inc.; Brenntag Biosector A/S; CSL Ltd.; Invivogen; Mvp Laboratories Inc.; Novavax, Inc.; OZ Biosciences SAS; Seppic SA; SPI Pharma



Download the full report: https://www.reportbuyer.com/product/5799883/?utm_source=PRN

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Vaccine Adjuvants Competitor Market Share Scenario Worldwide
(in %): 2019 & 2025
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Vaccine Adjuvants Global Market Estimates and
Forecasts in US$ Thousand by Region/Country: 2018-2025
Table 2: Vaccine Adjuvants Global Retrospective Market Scenario
in US$ Thousand by Region/Country: 2009-2017
Table 3: Vaccine Adjuvants Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Research (Application) Worldwide Sales in US$ Thousand
by Region/Country: 2018-2025
Table 5: Research (Application) Historic Demand Patterns in US$
Thousand by Region/Country: 2009-2017
Table 6: Research (Application) Market Share Shift across Key
Geographies: 2009 VS 2019 VS 2025
Table 7: Commercial (Application) Global Market Estimates &
Forecasts in US$ Thousand by Region/Country: 2018-2025
Table 8: Commercial (Application) Retrospective Demand Analysis
in US$ Thousand by Region/Country: 2009-2017
Table 9: Commercial (Application) Market Share Breakdown by
Region/Country: 2009 VS 2019 VS 2025
Table 10: Particulate Adjuvants (Type) World Market by
Region/Country in US$ Thousand: 2018 to 2025
Table 11: Particulate Adjuvants (Type) Historic Market Analysis
by Region/Country in US$ Thousand: 2009 to 2017
Table 12: Particulate Adjuvants (Type) Market Share Breakdown
of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 13: Adjuvant Emulsions (Type) Potential Growth Markets
Worldwide in US$ Thousand: 2018 to 2025
Table 14: Adjuvant Emulsions (Type) Historic Market Perspective
by Region/Country in US$ Thousand: 2009 to 2017
Table 15: Adjuvant Emulsions (Type) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 16: Pathogen Components (Type) Geographic Market Spread
Worldwide in US$ Thousand: 2018 to 2025
Table 17: Pathogen Components (Type) Region Wise Breakdown of
Global Historic Demand in US$ Thousand: 2009 to 2017
Table 18: Pathogen Components (Type) Market Share Distribution
in Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 19: Combination Adjuvants (Type) World Market Estimates
and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
Table 20: Combination Adjuvants (Type) Market Historic Review
by Region/Country in US$ Thousand: 2009 to 2017
Table 21: Combination Adjuvants (Type) Market Share Breakdown
by Region/Country: 2009 VS 2019 VS 2025
Table 22: Other Types (Type) World Market by Region/Country in
US$ Thousand: 2018 to 2025
Table 23: Other Types (Type) Historic Market Analysis by
Region/Country in US$ Thousand: 2009 to 2017
Table 24: Other Types (Type) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 25: Infectious Diseases (Disease Type) World Market
Estimates and Forecasts by Region/Country in US$ Thousand: 2018
to 2025
Table 26: Infectious Diseases (Disease Type) Market Historic
Review by Region/Country in US$ Thousand: 2009 to 2017
Table 27: Infectious Diseases (Disease Type) Market Share
Breakdown by Region/Country: 2009 VS 2019 VS 2025
Table 28: Cancer (Disease Type) World Market by Region/Country
in US$ Thousand: 2018 to 2025
Table 29: Cancer (Disease Type) Historic Market Analysis by
Region/Country in US$ Thousand: 2009 to 2017
Table 30: Cancer (Disease Type) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 31: Other Disease Types (Disease Type) World Market
Estimates and Forecasts in US$ Thousand by Region/Country: 2018
to 2025
Table 32: Other Disease Types (Disease Type) Market Worldwide
Historic Review by Region/Country in US$ Thousand: 2009 to 2017
Table 33: Other Disease Types (Disease Type) Market Percentage
Share Distribution by Region/Country: 2009 VS 2019 VS 2025
Table 34: Subcutaneous (Route of Administration) World Market
Estimates and Forecasts in US$ Thousand by Region/Country: 2018
to 2025
Table 35: Subcutaneous (Route of Administration) Market
Worldwide Historic Review by Region/Country in US$ Thousand:
2009 to 2017
Table 36: Subcutaneous (Route of Administration) Market
Percentage Share Distribution by Region/Country: 2009 VS 2019
VS 2025
Table 37: Intramuscular (Route of Administration) Market
Opportunity Analysis Worldwide in US$ Thousand by
Region/Country: 2018 to 2025
Table 38: Intramuscular (Route of Administration) Global
Historic Demand in US$ Thousand by Region/Country: 2009 to 2017
Table 39: Intramuscular (Route of Administration) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 40: Intranasal Route (Route of Administration) World
Market by Region/Country in US$ Thousand: 2018 to 2025
Table 41: Intranasal Route (Route of Administration) Historic
Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
Table 42: Intranasal Route (Route of Administration) Market
Share Breakdown of Worldwide Sales by Region/Country: 2009 VS
2019 VS 2025
Table 43: Oral Route (Route of Administration) Potential Growth
Markets Worldwide in US$ Thousand: 2018 to 2025
Table 44: Oral Route (Route of Administration) Historic Market
Perspective by Region/Country in US$ Thousand: 2009 to 2017
Table 45: Oral Route (Route of Administration) Market Sales
Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 46: Other Route of Administrations (Route of
Administration) Geographic Market Spread Worldwide in US$
Thousand: 2018 to 2025
Table 47: Other Route of Administrations (Route of
Administration) Region Wise Breakdown of Global Historic Demand
in US$ Thousand: 2009 to 2017
Table 48: Other Route of Administrations (Route of
Administration) Market Share Distribution in Percentage by
Region/Country: 2009 VS 2019 VS 2025
Table 49: Human Vaccine Adjuvants (Application Category)
Potential Growth Markets Worldwide in US$ Thousand: 2018 to
2025
Table 50: Human Vaccine Adjuvants (Application Category)
Historic Market Perspective by Region/Country in US$ Thousand:
2009 to 2017
Table 51: Human Vaccine Adjuvants (Application Category) Market
Sales Breakdown by Region/Country in Percentage: 2009 VS 2019
VS 2025
Table 52: Veterinary Vaccine Adjuvants (Application Category)
Geographic Market Spread Worldwide in US$ Thousand: 2018 to
2025
Table 53: Veterinary Vaccine Adjuvants (Application Category)
Region Wise Breakdown of Global Historic Demand in US$
Thousand: 2009 to 2017
Table 54: Veterinary Vaccine Adjuvants (Application Category)
Market Share Distribution in Percentage by Region/Country: 2009
VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Vaccine Adjuvants Market Share (in %) by Company: 2019 & 2025
Table 55: United States Vaccine Adjuvants Latent Demand
Forecasts in US$ Thousand by Application: 2018 to 2025
Table 56: Vaccine Adjuvants Historic Demand Patterns in the
United States by Application in US$ Thousand for 2009-2017
Table 57: Vaccine Adjuvants Market Share Breakdown in the
United States by Application: 2009 VS 2019 VS 2025
Table 58: United States Vaccine Adjuvants Market Estimates and
Projections in US$ Thousand by Type: 2018 to 2025
Table 59: Vaccine Adjuvants Market in the United States by
Type: A Historic Review in US$ Thousand for 2009-2017
Table 60: United States Vaccine Adjuvants Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 61: United States Vaccine Adjuvants Market Estimates and
Projections in US$ Thousand by Disease Type: 2018 to 2025
Table 62: Vaccine Adjuvants Market in the United States by
Disease Type: A Historic Review in US$ Thousand for 2009-2017
Table 63: United States Vaccine Adjuvants Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 64: United States Vaccine Adjuvants Market Estimates and
Projections in US$ Thousand by Route of Administration: 2018 to
2025
Table 65: Vaccine Adjuvants Market in the United States by
Route of Administration: A Historic Review in US$ Thousand for
2009-2017
Table 66: United States Vaccine Adjuvants Market Share
Breakdown by Route of Administration: 2009 VS 2019 VS 2025
Table 67: United States Vaccine Adjuvants Market Estimates and
Projections in US$ Thousand by Application Category: 2018 to
2025
Table 68: Vaccine Adjuvants Market in the United States by
Application Category: A Historic Review in US$ Thousand for
2009-2017
Table 69: United States Vaccine Adjuvants Market Share
Breakdown by Application Category: 2009 VS 2019 VS 2025
CANADA
Table 70: Canadian Vaccine Adjuvants Market Quantitative Demand
Analysis in US$ Thousand by Application: 2018 to 2025
Table 71: Vaccine Adjuvants Market in Canada: Summarization of
Historic Demand Patterns in US$ Thousand by Application for
2009-2017
Table 72: Canadian Vaccine Adjuvants Market Share Analysis by
Application: 2009 VS 2019 VS 2025
Table 73: Canadian Vaccine Adjuvants Market Estimates and
Forecasts in US$ Thousand by Type: 2018 to 2025
Table 74: Canadian Vaccine Adjuvants Historic Market Review by
Type in US$ Thousand: 2009-2017
Table 75: Vaccine Adjuvants Market in Canada: Percentage Share
Breakdown of Sales by Type for 2009, 2019, and 2025
Table 76: Canadian Vaccine Adjuvants Market Estimates and
Forecasts in US$ Thousand by Disease Type: 2018 to 2025
Table 77: Canadian Vaccine Adjuvants Historic Market Review by
Disease Type in US$ Thousand: 2009-2017
Table 78: Vaccine Adjuvants Market in Canada: Percentage Share
Breakdown of Sales by Disease Type for 2009, 2019, and 2025
Table 79: Canadian Vaccine Adjuvants Market Estimates and
Forecasts in US$ Thousand by Route of Administration: 2018 to
2025
Table 80: Canadian Vaccine Adjuvants Historic Market Review by
Route of Administration in US$ Thousand: 2009-2017
Table 81: Vaccine Adjuvants Market in Canada: Percentage Share
Breakdown of Sales by Route of Administration for 2009, 2019,
and 2025
Table 82: Canadian Vaccine Adjuvants Market Estimates and
Forecasts in US$ Thousand by Application Category: 2018 to 2025
Table 83: Canadian Vaccine Adjuvants Historic Market Review by
Application Category in US$ Thousand: 2009-2017
Table 84: Vaccine Adjuvants Market in Canada: Percentage Share
Breakdown of Sales by Application Category for 2009, 2019, and
2025
JAPAN
Table 85: Japanese Demand Estimates and Forecasts for Vaccine
Adjuvants in US$ Thousand by Application: 2018 to 2025
Table 86: Japanese Vaccine Adjuvants Market in US$ Thousand by
Application: 2009-2017
Table 87: Vaccine Adjuvants Market Share Shift in Japan by
Application: 2009 VS 2019 VS 2025
Table 88: Japanese Market for Vaccine Adjuvants: Annual Sales
Estimates and Projections in US$ Thousand by Type for the
Period 2018-2025
Table 89: Vaccine Adjuvants Market in Japan: Historic Sales
Analysis in US$ Thousand by Type for the Period 2009-2017
Table 90: Japanese Vaccine Adjuvants Market Share Analysis by
Type: 2009 VS 2019 VS 2025
Table 91: Japanese Market for Vaccine Adjuvants: Annual Sales
Estimates and Projections in US$ Thousand by Disease Type for
the Period 2018-2025
Table 92: Vaccine Adjuvants Market in Japan: Historic Sales
Analysis in US$ Thousand by Disease Type for the Period
2009-2017
Table 93: Japanese Vaccine Adjuvants Market Share Analysis by
Disease Type: 2009 VS 2019 VS 2025
Table 94: Japanese Market for Vaccine Adjuvants: Annual Sales
Estimates and Projections in US$ Thousand by Route of
Administration for the Period 2018-2025
Table 95: Vaccine Adjuvants Market in Japan: Historic Sales
Analysis in US$ Thousand by Route of Administration for the
Period 2009-2017
Table 96: Japanese Vaccine Adjuvants Market Share Analysis by
Route of Administration: 2009 VS 2019 VS 2025
Table 97: Japanese Market for Vaccine Adjuvants: Annual Sales
Estimates and Projections in US$ Thousand by Application
Category for the Period 2018-2025
Table 98: Vaccine Adjuvants Market in Japan: Historic Sales
Analysis in US$ Thousand by Application Category for the Period
2009-2017
Table 99: Japanese Vaccine Adjuvants Market Share Analysis by
Application Category: 2009 VS 2019 VS 2025
CHINA
Table 100: Chinese Demand for Vaccine Adjuvants in US$ Thousand
by Application: 2018 to 2025
Table 101: Vaccine Adjuvants Market Review in China in US$
Thousand by Application: 2009-2017
Table 102: Chinese Vaccine Adjuvants Market Share Breakdown by
Application: 2009 VS 2019 VS 2025
Table 103: Chinese Vaccine Adjuvants Market Growth Prospects in
US$ Thousand by Type for the Period 2018-2025
Table 104: Vaccine Adjuvants Historic Market Analysis in China
in US$ Thousand by Type: 2009-2017
Table 105: Chinese Vaccine Adjuvants Market by Type: Percentage
Breakdown of Sales for 2009, 2019, and 2025
Table 106: Chinese Vaccine Adjuvants Market Growth Prospects in
US$ Thousand by Disease Type for the Period 2018-2025
Table 107: Vaccine Adjuvants Historic Market Analysis in China
in US$ Thousand by Disease Type: 2009-2017
Table 108: Chinese Vaccine Adjuvants Market by Disease Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 109: Chinese Vaccine Adjuvants Market Growth Prospects in
US$ Thousand by Route of Administration for the Period
2018-2025
Table 110: Vaccine Adjuvants Historic Market Analysis in China
in US$ Thousand by Route of Administration: 2009-2017
Table 111: Chinese Vaccine Adjuvants Market by Route of
Administration: Percentage Breakdown of Sales for 2009, 2019,
and 2025
Table 112: Chinese Vaccine Adjuvants Market Growth Prospects in
US$ Thousand by Application Category for the Period 2018-2025
Table 113: Vaccine Adjuvants Historic Market Analysis in China
in US$ Thousand by Application Category: 2009-2017
Table 114: Chinese Vaccine Adjuvants Market by Application
Category: Percentage Breakdown of Sales for 2009, 2019, and
2025
EUROPE
Market Facts & Figures
European Vaccine Adjuvants Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Table 115: European Vaccine Adjuvants Market Demand Scenario in
US$ Thousand by Region/Country: 2018-2025
Table 116: Vaccine Adjuvants Market in Europe: A Historic
Market Perspective in US$ Thousand by Region/Country for the
Period 2009-2017
Table 117: European Vaccine Adjuvants Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 118: European Vaccine Adjuvants Addressable Market
Opportunity in US$ Thousand by Application: 2018-2025
Table 119: Vaccine Adjuvants Market in Europe: Summarization of
Historic Demand in US$ Thousand by Application for the Period
2009-2017
Table 120: European Vaccine Adjuvants Market Share Analysis by
Application: 2009 VS 2019 VS 2025
Table 121: European Vaccine Adjuvants Market Estimates and
Forecasts in US$ Thousand by Type: 2018-2025
Table 122: Vaccine Adjuvants Market in Europe in US$ Thousand
by Type: A Historic Review for the Period 2009-2017
Table 123: European Vaccine Adjuvants Market Share Breakdown by
Type: 2009 VS 2019 VS 2025
Table 124: European Vaccine Adjuvants Market Estimates and
Forecasts in US$ Thousand by Disease Type: 2018-2025
Table 125: Vaccine Adjuvants Market in Europe in US$ Thousand
by Disease Type: A Historic Review for the Period 2009-2017
Table 126: European Vaccine Adjuvants Market Share Breakdown by
Disease Type: 2009 VS 2019 VS 2025
Table 127: European Vaccine Adjuvants Market Estimates and
Forecasts in US$ Thousand by Route of Administration: 2018-2025
Table 128: Vaccine Adjuvants Market in Europe in US$ Thousand
by Route of Administration: A Historic Review for the Period
2009-2017
Table 129: European Vaccine Adjuvants Market Share Breakdown by
Route of Administration: 2009 VS 2019 VS 2025
Table 130: European Vaccine Adjuvants Market Estimates and
Forecasts in US$ Thousand by Application Category: 2018-2025
Table 131: Vaccine Adjuvants Market in Europe in US$ Thousand
by Application Category: A Historic Review for the Period
2009-2017
Table 132: European Vaccine Adjuvants Market Share Breakdown by
Application Category: 2009 VS 2019 VS 2025
FRANCE
Table 133: Vaccine Adjuvants Quantitative Demand Analysis in
France in US$ Thousand by Application: 2018-2025
Table 134: French Vaccine Adjuvants Historic Market Review in
US$ Thousand by Application: 2009-2017
Table 135: French Vaccine Adjuvants Market Share Analysis: A
17-Year Perspective by Application for 2009, 2019, and 2025
Table 136: Vaccine Adjuvants Market in France by Type:
Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 137: French Vaccine Adjuvants Historic Market Scenario in
US$ Thousand by Type: 2009-2017
Table 138: French Vaccine Adjuvants Market Share Analysis by
Type: 2009 VS 2019 VS 2025
Table 139: Vaccine Adjuvants Market in France by Disease Type:
Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 140: French Vaccine Adjuvants Historic Market Scenario in
US$ Thousand by Disease Type: 2009-2017
Table 141: French Vaccine Adjuvants Market Share Analysis by
Disease Type: 2009 VS 2019 VS 2025
Table 142: Vaccine Adjuvants Market in France by Route of
Administration: Estimates and Projections in US$ Thousand for
the Period 2018-2025
Table 143: French Vaccine Adjuvants Historic Market Scenario in
US$ Thousand by Route of Administration: 2009-2017
Table 144: French Vaccine Adjuvants Market Share Analysis by
Route of Administration: 2009 VS 2019 VS 2025
Table 145: Vaccine Adjuvants Market in France by Application
Category: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 146: French Vaccine Adjuvants Historic Market Scenario in
US$ Thousand by Application Category: 2009-2017
Table 147: French Vaccine Adjuvants Market Share Analysis by
Application Category: 2009 VS 2019 VS 2025
GERMANY
Table 148: Vaccine Adjuvants Market in Germany: Annual Sales
Estimates and Forecasts in US$ Thousand by Application for the
Period 2018-2025
Table 149: German Vaccine Adjuvants Market in Retrospect in US$
Thousand by Application: 2009-2017
Table 150: Vaccine Adjuvants Market Share Distribution in
Germany by Application: 2009 VS 2019 VS 2025
Table 151: Vaccine Adjuvants Market in Germany: Recent Past,
Current and Future Analysis in US$ Thousand by Type for the
Period 2018-2025
Table 152: German Vaccine Adjuvants Historic Market Analysis in
US$ Thousand by Type: 2009-2017
Table 153: German Vaccine Adjuvants Market Share Breakdown by
Type: 2009 VS 2019 VS 2025
Table 154: Vaccine Adjuvants Market in Germany: Recent Past,
Current and Future Analysis in US$ Thousand by Disease Type for
the Period 2018-2025
Table 155: German Vaccine Adjuvants Historic Market Analysis in
US$ Thousand by Disease Type: 2009-2017
Table 156: German Vaccine Adjuvants Market Share Breakdown by
Disease Type: 2009 VS 2019 VS 2025
Table 157: Vaccine Adjuvants Market in Germany: Recent Past,
Current and Future Analysis in US$ Thousand by Route of
Administration for the Period 2018-2025
Table 158: German Vaccine Adjuvants Historic Market Analysis in
US$ Thousand by Route of Administration: 2009-2017
Table 159: German Vaccine Adjuvants Market Share Breakdown by
Route of Administration: 2009 VS 2019 VS 2025
Table 160: Vaccine Adjuvants Market in Germany: Recent Past,
Current and Future Analysis in US$ Thousand by Application
Category for the Period 2018-2025
Table 161: German Vaccine Adjuvants Historic Market Analysis in
US$ Thousand by Application Category: 2009-2017
Table 162: German Vaccine Adjuvants Market Share Breakdown by
Application Category: 2009 VS 2019 VS 2025
ITALY
Table 163: Italian Demand for Vaccine Adjuvants in US$ Thousand
by Application: 2018 to 2025
Table 164: Vaccine Adjuvants Market Review in Italy in US$
Thousand by Application: 2009-2017
Table 165: Italian Vaccine Adjuvants Market Share Breakdown by
Application: 2009 VS 2019 VS 2025
Table 166: Italian Vaccine Adjuvants Market Growth Prospects in
US$ Thousand by Type for the Period 2018-2025
Table 167: Vaccine Adjuvants Historic Market Analysis in Italy
in US$ Thousand by Type: 2009-2017
Table 168: Italian Vaccine Adjuvants Market by Type: Percentage
Breakdown of Sales for 2009, 2019, and 2025
Table 169: Italian Vaccine Adjuvants Market Growth Prospects in
US$ Thousand by Disease Type for the Period 2018-2025
Table 170: Vaccine Adjuvants Historic Market Analysis in Italy
in US$ Thousand by Disease Type: 2009-2017
Table 171: Italian Vaccine Adjuvants Market by Disease Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 172: Italian Vaccine Adjuvants Market Growth Prospects in
US$ Thousand by Route of Administration for the Period
2018-2025
Table 173: Vaccine Adjuvants Historic Market Analysis in Italy
in US$ Thousand by Route of Administration: 2009-2017
Table 174: Italian Vaccine Adjuvants Market by Route of
Administration: Percentage Breakdown of Sales for 2009, 2019,
and 2025
Table 175: Italian Vaccine Adjuvants Market Growth Prospects in
US$ Thousand by Application Category for the Period 2018-2025
Table 176: Vaccine Adjuvants Historic Market Analysis in Italy
in US$ Thousand by Application Category: 2009-2017
Table 177: Italian Vaccine Adjuvants Market by Application
Category: Percentage Breakdown of Sales for 2009, 2019, and
2025
UNITED KINGDOM
Table 178: United Kingdom Demand Estimates and Forecasts for
Vaccine Adjuvants in US$ Thousand by Application: 2018 to 2025
Table 179: United Kingdom Vaccine Adjuvants Market in US$
Thousand by Application: 2009-2017
Table 180: Vaccine Adjuvants Market Share Shift in the United
Kingdom by Application: 2009 VS 2019 VS 2025
Table 181: United Kingdom Market for Vaccine Adjuvants: Annual
Sales Estimates and Projections in US$ Thousand by Type for the
Period 2018-2025
Table 182: Vaccine Adjuvants Market in the United Kingdom:
Historic Sales Analysis in US$ Thousand by Type for the Period
2009-2017
Table 183: United Kingdom Vaccine Adjuvants Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 184: United Kingdom Market for Vaccine Adjuvants: Annual
Sales Estimates and Projections in US$ Thousand by Disease Type
for the Period 2018-2025
Table 185: Vaccine Adjuvants Market in the United Kingdom:
Historic Sales Analysis in US$ Thousand by Disease Type for the
Period 2009-2017
Table 186: United Kingdom Vaccine Adjuvants Market Share
Analysis by Disease Type: 2009 VS 2019 VS 2025
Table 187: United Kingdom Market for Vaccine Adjuvants: Annual
Sales Estimates and Projections in US$ Thousand by Route of
Administration for the Period 2018-2025
Table 188: Vaccine Adjuvants Market in the United Kingdom:
Historic Sales Analysis in US$ Thousand by Route of
Administration for the Period 2009-2017
Table 189: United Kingdom Vaccine Adjuvants Market Share
Analysis by Route of Administration: 2009 VS 2019 VS 2025
Table 190: United Kingdom Market for Vaccine Adjuvants: Annual
Sales Estimates and Projections in US$ Thousand by Application
Category for the Period 2018-2025
Table 191: Vaccine Adjuvants Market in the United Kingdom:
Historic Sales Analysis in US$ Thousand by Application Category
for the Period 2009-2017
Table 192: United Kingdom Vaccine Adjuvants Market Share
Analysis by Application Category: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 193: Rest of Europe Vaccine Adjuvants Addressable Market
Opportunity in US$ Thousand by Application: 2018-2025
Table 194: Vaccine Adjuvants Market in Rest of Europe:
Summarization of Historic Demand in US$ Thousand by Application
for the Period 2009-2017
Table 195: Rest of Europe Vaccine Adjuvants Market Share
Analysis by Application: 2009 VS 2019 VS 2025
Table 196: Rest of Europe Vaccine Adjuvants Market Estimates
and Forecasts in US$ Thousand by Type: 2018-2025
Table 197: Vaccine Adjuvants Market in Rest of Europe in US$
Thousand by Type: A Historic Review for the Period 2009-2017
Table 198: Rest of Europe Vaccine Adjuvants Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 199: Rest of Europe Vaccine Adjuvants Market Estimates
and Forecasts in US$ Thousand by Disease Type: 2018-2025
Table 200: Vaccine Adjuvants Market in Rest of Europe in US$
Thousand by Disease Type: A Historic Review for the Period
2009-2017
Table 201: Rest of Europe Vaccine Adjuvants Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 202: Rest of Europe Vaccine Adjuvants Market Estimates
and Forecasts in US$ Thousand by Route of Administration:
2018-2025
Table 203: Vaccine Adjuvants Market in Rest of Europe in US$
Thousand by Route of Administration: A Historic Review for the
Period 2009-2017
Table 204: Rest of Europe Vaccine Adjuvants Market Share
Breakdown by Route of Administration: 2009 VS 2019 VS 2025
Table 205: Rest of Europe Vaccine Adjuvants Market Estimates
and Forecasts in US$ Thousand by Application Category:
2018-2025
Table 206: Vaccine Adjuvants Market in Rest of Europe in US$
Thousand by Application Category: A Historic Review for the
Period 2009-2017
Table 207: Rest of Europe Vaccine Adjuvants Market Share
Breakdown by Application Category: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 208: Vaccine Adjuvants Quantitative Demand Analysis in
Asia-Pacific in US$ Thousand by Application: 2018-2025
Table 209: Asia-Pacific Vaccine Adjuvants Historic Market
Review in US$ Thousand by Application: 2009-2017
Table 210: Asia-Pacific Vaccine Adjuvants Market Share
Analysis: A 17-Year Perspective by Application for 2009, 2019,
and 2025
Table 211: Vaccine Adjuvants Market in Asia-Pacific by Type:
Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 212: Asia-Pacific Vaccine Adjuvants Historic Market
Scenario in US$ Thousand by Type: 2009-2017
Table 213: Asia-Pacific Vaccine Adjuvants Market Share Analysis
by Type: 2009 VS 2019 VS 2025
Table 214: Vaccine Adjuvants Market in Asia-Pacific by Disease
Type: Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 215: Asia-Pacific Vaccine Adjuvants Historic Market
Scenario in US$ Thousand by Disease Type: 2009-2017
Table 216: Asia-Pacific Vaccine Adjuvants Market Share Analysis
by Disease Type: 2009 VS 2019 VS 2025
Table 217: Vaccine Adjuvants Market in Asia-Pacific by Route of
Administration: Estimates and Projections in US$ Thousand for
the Period 2018-2025
Table 218: Asia-Pacific Vaccine Adjuvants Historic Market
Scenario in US$ Thousand by Route of Administration: 2009-2017
Table 219: Asia-Pacific Vaccine Adjuvants Market Share Analysis
by Route of Administration: 2009 VS 2019 VS 2025
Table 220: Vaccine Adjuvants Market in Asia-Pacific by
Application Category: Estimates and Projections in US$ Thousand
for the Period 2018-2025
Table 221: Asia-Pacific Vaccine Adjuvants Historic Market
Scenario in US$ Thousand by Application Category: 2009-2017
Table 222: Asia-Pacific Vaccine Adjuvants Market Share Analysis
by Application Category: 2009 VS 2019 VS 2025
REST OF WORLD
Table 223: Rest of World Vaccine Adjuvants Market Quantitative
Demand Analysis in US$ Thousand by Application: 2018 to 2025
Table 224: Vaccine Adjuvants Market in Rest of World:
Summarization of Historic Demand Patterns in US$ Thousand by
Application for 2009-2017
Table 225: Rest of World Vaccine Adjuvants Market Share
Analysis by Application: 2009 VS 2019 VS 2025
Table 226: Rest of World Vaccine Adjuvants Market Estimates and
Forecasts in US$ Thousand by Type: 2018 to 2025
Table 227: Rest of World Vaccine Adjuvants Historic Market
Review by Type in US$ Thousand: 2009-2017
Table 228: Vaccine Adjuvants Market in Rest of World:
Percentage Share Breakdown of Sales by Type for 2009, 2019, and
2025
Table 229: Rest of World Vaccine Adjuvants Market Estimates and
Forecasts in US$ Thousand by Disease Type: 2018 to 2025
Table 230: Rest of World Vaccine Adjuvants Historic Market
Review by Disease Type in US$ Thousand: 2009-2017
Table 231: Vaccine Adjuvants Market in Rest of World:
Percentage Share Breakdown of Sales by Disease Type for 2009,
2019, and 2025
Table 232: Rest of World Vaccine Adjuvants Market Estimates and
Forecasts in US$ Thousand by Route of Administration: 2018 to
2025
Table 233: Rest of World Vaccine Adjuvants Historic Market
Review by Route of Administration in US$ Thousand: 2009-2017
Table 234: Vaccine Adjuvants Market in Rest of World:
Percentage Share Breakdown of Sales by Route of Administration
for 2009, 2019, and 2025
Table 235: Rest of World Vaccine Adjuvants Market Estimates and
Forecasts in US$ Thousand by Application Category: 2018 to 2025
Table 236: Rest of World Vaccine Adjuvants Historic Market
Review by Application Category in US$ Thousand: 2009-2017
Table 237: Vaccine Adjuvants Market in Rest of World:
Percentage Share Breakdown of Sales by Application Category for
2009, 2019, and 2025

IV. COMPETITION

AGENUS, INC.
AVANTI POLAR LIPIDS, INC.
BRENNTAG BIOSECTOR A/S (A SUBSIDIARY OF BRENNTAG AG)
CSL
INVIVOGEN
MVP LABORATORIES
NOVAVAX
OZ BIOSCIENCES SAS
SPI PHARMA
SEPPIC SA

V. CURATED RESEARCH
Download the full report: https://www.reportbuyer.com/product/5799883/?utm_source=PRN

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

View original content:http://www.prnewswire.com/news-releases/global-vaccine-adjuvants-industry-300947263.html

SOURCE ReportBuyer